Back
ProShares UltraShort Nasdaq Biotech Vs. ProShares UltraShort MidCap400 Industry Stock Comparison
Sell
40
BIS
ProShares UltraShort Nasdaq Biotech
Last Price:
16.22
Seasonality Move:
-11.25%
Sell
23
MZZ
ProShares UltraShort MidCap400
Last Price:
9.17
Seasonality Move:
-9.83%
Sell
40
ProShares UltraShort Nasdaq Biotech (BIS)
is a Sell
Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?
- The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $15.48. The Score for BIS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- BIS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
ProShares UltraShort MidCap400 (MZZ)
is a Sell
Is ProShares UltraShort MidCap400 a Buy, Sell or Hold?
- The current ProShares UltraShort MidCap400 [MZZ] share price is $9.01. The Score for MZZ is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- MZZ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIS Stock Price Chart
What is ProShares UltraShort Nasdaq Biotech's stock price today?
-
The ProShares UltraShort Nasdaq Biotech share price today is $15.48
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MZZ Stock Price Chart
What is ProShares UltraShort MidCap400's stock price today?
-
The ProShares UltraShort MidCap400 share price today is $9.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MZZ is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 55.02 | Buy |
| Chaikin Money Flow: | 14190 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.74 - 15.56) | Buy |
| Bollinger Bands (100): | (14.55 - 15.91) | Buy |
MZZ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 36.07 | Sell |
| Chaikin Money Flow: | 1836 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.15 - 9.99) | Sell |
| Bollinger Bands (100): | (9.7 - 11.2) | Sell |
BIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.96 | Buy |
| 20-day SMA: | 15.18 | Buy |
| 50-day SMA: | 15.13 | Buy |
| 200-day SMA: | 16.65 | Sell |
| 8-day EMA: | 15.06 | Buy |
| 20-day EMA: | 15.13 | Buy |
| 50-day EMA: | 15.19 | Buy |
| 200-day EMA: | 16.62 | Sell |
MZZ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.14 | Sell |
| 20-day SMA: | 9.54 | Sell |
| 50-day SMA: | 9.97 | Sell |
| 200-day SMA: | 11 | Sell |
| 8-day EMA: | 9.12 | Sell |
| 20-day EMA: | 9.44 | Sell |
| 50-day EMA: | 9.86 | Sell |
| 200-day EMA: | 11.18 | Sell |
ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares UltraShort MidCap400 Earnings Growth & MZZ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares UltraShort Nasdaq Biotech Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares UltraShort MidCap400 Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||